Home > Breakthroughs at Centenary Institute
Centenary Institute - Medical Research
Centenary Institute - Medical Research

Breakthroughs at Centenary Institute

As a world-leading independent Medical Research Institute for over 30 years we have had significant breakthroughs and impacted medical research in the areas of cancer, inflammation and cardiovascular.

Improved the diagnosis rate of a potentially deadly heart condition by up to 20 per cent.

Molecular Cardiology Program

Discovered a potential new pathway for cancer therapies.

Liver Enzymes in Metabolism and Inflammation Program

Boosted the human body’s fight against melanoma by uncovering a new pathway in the body.

Skin Imaging and Inflammation Laboratory

Uncovered a brand new virus underpinning kidney disease.

Skin Imaging and Inflammation Laboratory

Created a more realistic model of primary liver cancer.

Liver Enzymes in Metabolism and Inflammation Program

Gained new insight into the never-ending arms race between viruses and their hosts.

DNA Repair Laboratory

Determined how to develop safer blood-clotting drugs.

ACRF Centenary Cancer Research Centre

Progressed towards developing a more effective vaccine against tuberculosis.

Tuberculosis Program

Uncovered the causes and mechanisms of Alzheimer’s disease.

Lipid Metabolism and Neurochemistry Laboratory

Discovered a cure for a sub-set of one of the most common genetic blood diseases in the world, Beta-thalassemia.

Gene and Stem Cell Therapy Program

Developed a novel drug which is being touted as a major step forward in the battle against obesity.

Lipid Metabolism and Neurochemistry Laboratory

Identified a drug currently used to treat cancer patients as a potential therapy for a leading cause of stroke.

Cell Signalling Laboratory

2017

Discovered a new cell in the liver, which will inform future investigations into liver disease and liver cancer.

Liver Immunology Program

Revealed evidence of a new target that could be the key to treating liver fibrosis.

Liver Enzymes in Metabolism and Inflammation Program

Discovered that gut bacteria could hold the key to treating and preventing potentially deadly strokes.

Cell Signalling Laboratory

Published a world-first study finding that having just one or two energy drinks could be life threatening for some young people with no known history of heart disease.

Molecular Cardiology Program

Identified antibacterial compounds in soil that could lead to new treatments for tuberculosis.

Tuberculosis Program

Discovered a common pattern in the process of gene regulation that could be the key to treating and finding cures for cancers and other diseases.

Gene and Stem Cell Therapy Program

Developed a new drug that could be effective in some of the hardest to treat cancers such as pancreatic and liver cancer.

Vascular Biology Program

More significant breakthroughs in medical research

2016

Identified a gene essential for stem cell potency.

DNA Repair Laboratory

Discovered a new population of white blood cells in the liver that protects against Malaria.

Liver Immunology Program

Further developed our drugs against breast cancer and melanoma.

ACRF Centenary Cancer Research Centre

Discovered evidence that a new blood test we developed is a useful diagnosing liver scarring in patients.

Liver Enzymes in Metabolism and Inflammation Program

2015

Discovered molecular change driving blood cell development.

Gene and Stem Cell Therapy Program and Bioinformatics

2013

Discovered a new immune cell type that causes skin diseases and skin allergies.

Immune Imaging Program

2012

Discovered new drug candidates for prostate and breast cancer.

Origins of Cancer Program

2011

Developed an integrated genetic and clinical approach for early diagnosis and treatment solutions to prevent sudden cardiac death.

Molecular Cardiology Program

Discovery of a new mechanism by which the liver kills immune cells responsible for graft rejection and viral clearance.

Liver Immunology Program

2009

Discovered micro RNA can be used to treat diseases associated with vascular leak eg stroke and myocardinal infarction.

Vascular Biology Program

2005

Discovered anti TNF therapy increases the risk of reactivation of Tuberculosis.

Tuberculosis Program

Improved the identification of human regulatory T Cells, a discovery used widely in clinical research settings.

T Cell Biology Program

1989

Discovered critical insights into the role of the immune system in health and disease.

B Cell Program

Improved the diagnosis rate of a potentially deadly heart condition by up to 20 per cent.

Molecular Cardiology Program

Discovered a potential new pathway for cancer therapies.

Liver Enzymes in Metabolism and Inflammation Program

Boosted the human body’s fight against melanoma by uncovering a new pathway in the body.

Skin Imaging and Inflammation Laboratory

//